(Q57024141)

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.06.004

RO1138452 and RO3244794: characterization of structurally distinct, potent and selective IP (prostacyclin) receptor antagonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.06.004

Molecular cloning and characterization of the four rat prostaglandin E2 prostanoid receptor subtypes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.06.004

Responses of human and baboon arteries to prostaglandin endoperoxides and biologically generated and synthetic prostacyclin: their relevance to cerebral arterial spasm in man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.06.004

An update on the blood vessel in migraine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.06.004

Potential mechanisms of prospective antimigraine drugs: a focus on vascular (side) effects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.06.004

Discovery and SAR development of 2-(phenylamino) imidazolines as prostacyclin receptor antagonists [corrected].

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.06.004

EP4 prostanoid receptor-mediated vasodilatation of human middle cerebral arteries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.06.004

Improvement of the closed cranial window model in rats by intracarotid infusion of signalling molecules implicated in migraine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.06.004

Prostaglandins facilitate peptide release from rat sensory neurons by activating the adenosine 3',5'-cyclic monophosphate transduction cascade

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.06.004

Activation of the PGI(2)/IP system contributes to the development of circulatory failure in a rat model of endotoxic shock.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.06.004

Actions of some prostaglandins and leukotrienes on rat cerebral and mesenteric arteries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.06.004

Characterization of the prostanoid receptor types involved in mediating calcitonin gene-related peptide release from cultured rat trigeminal neurones

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.06.004

Ligand binding specificities of the eight types and subtypes of the mouse prostanoid receptors expressed in Chinese hamster ovary cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.06.004

CGRP may play a causative role in migraine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.06.004

Distinct sensitizing effects of the cAMP-PKA second messenger cascade on rat dural mechanonociceptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.06.004

BGC20-1531, a novel, potent and selective prostanoid EP receptor antagonist: a putative new treatment for migraine headache

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.06.004

Primate vascular responses to octimibate, a non-prostanoid agonist at the prostacyclin receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.06.004

Role of nitric oxide and prostacyclin as vasoactive hormones released by the endothelium.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.06.004

Functional and molecular characterization of prostaglandin E2 dilatory receptors in the rat craniovascular system in relevance to migraine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.06.004

In situ hybridization studies of prostacyclin receptor mRNA expression in various mouse organs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.06.004

Effect of Hypotension and Carbon Dioxide Changes in an Improved Genuine Closed Cranial Window Rat Model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.06.004

Nitric oxide metabolites, prostaglandins and trigeminal vasoactive peptides in internal jugular vein blood during spontaneous migraine attacks

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.06.004

Human prostacyclin receptor structure and function from naturally-occurring and synthetic mutations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.06.004

Cerebrovascular effects of prostanoids: in-vitro studies in feline middle cerebral and basilar artery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.06.004

Prostacyclin (epoprostenol) induces headache in healthy subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.06.004

Prostaglandin I2 (epoprostenol) triggers migraine-like attacks in migraineurs.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.06.004

Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.06.004

Prostanoids in nociception and pain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.06.004

Sensitization and activation of intracranial meningeal nociceptors by mast cell mediators.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.06.004